Abstract
Spiramycin-chitosan Nanoparticles Decline Parasite Burden and Renovate Patent Histopathological Changes in Liver and Lung in Mice Experimentally Infected with Acute Toxoplasmosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have